Community Research Foundation, Inc.

Miami, Florida 33155

0 studies enrolling now · 12 studies all time

What they study most

Atopic Dermatitis, Chronic Disease, Chronic Idiopathic Constipation, Crohn Disease, Crohn's Disease, Hypercholesterolemia, Osteoarthritis, Osteoarthritis, Knee, Pain, Type 2 Diabetes

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed
• Tanezumab In Osteoarthritis Of The Hip Or Knee — Stopped early
• A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain — Stopped early
• Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin — Completed
• Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation — Completed
• Conversion to Embeda With Rescue Trial — Stopped early